Tech Company Financing Transactions
Zepto Life Technology Funding Round
Zepto Life Technology secured a $8.9 million investment round on 8/11/2026. Backers included National Institutes of Health.
Transaction Overview
Company Name
Announced On
8/11/2026
Transaction Type
Debt
Amount
$8,900,000
Round
Undisclosed
Investors
Proceeds Purpose
This award helps us advance Zepto's technology as a deployable liquid biopsy platform for infectious disease and bring that capability directly into hospital microbiology laboratories.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1000 Westgate Drive 2000
Saint Paul, MN 55114
USA
Saint Paul, MN 55114
USA
Phone
Website
Email Address
Overview
Zepto Life Technology is a molecular diagnostics company bringing plasma cell-free DNA (cfDNA) liquid biopsy testing into infectious disease. Through its CLIA-certified reference laboratory, Zepto offers the growing FungiFlex® menu for minimally invasive, targeted identification of fungal pathogens directly from plasma. The company is also advancing the Zepto MDx� platform to bring sample-to-result liquid biopsy testing directly into hospital and clinical microbiology laboratories.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hannah Zhang
Chief Medical Officer
Dong Chen
VP - Bus. Development
Xiaoying Liu
VP - Engineering
Keping Song
VP - Regulatory Affairs
Wei Wang
Browse more venture capital transactions:
Prev: 8/11/2026: House of Student venture capital transaction
Next: 8/11/2026: AquaNab venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs